TherapeuticsMD more than triples on deal to be acquired by EW Healthcare

TherapeuticsMD

31/05/2022 11:41

** Shares of TherapeuticsMD Inc  TXMD.O  rise ~352% to $9.69
premarket
    ** Women-focused therapy maker enters into definitive merger
agreement to be taken private by an affiliate of EW Healthcare
Partners in an all-cash transaction (https://refini.tv/3lXAlsd)
    ** EW Healthcare Partners, a private equity firm, to acquire
all outstanding shares of TXMD common stock for $10.00/shr,
representing a premium of 367.3% over TXMD's last closing price 
    ** Transaction implies a total enterprise value for TXMD of
~$177 mln 
    ** Combination expected to be completed by July 13
    ** Stock lost ~88% this year, as of last close

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))